Predictive Oncology INC

Axe Compute Inc. announced a significant five-year, $1.5 billion contract to deploy a dedicated AI infrastructure cluster in the U.S., boosting its 2026 signed contract value to over $3 billion.

Axe Compute Inc. announced it has secured over $1.3 billion in new customer contracts for its AI infrastructure build program, exceeding its annual goal.

Axe Compute Inc. has filed an 8-K to update its risk factors, reflecting a strategic shift toward a capital-intensive, owned-asset GPU infrastructure model.

Axe Compute Inc. has filed a prospectus supplement to increase its at-the-market (ATM) equity offering capacity to $100 million.

Axe Compute Inc. will host a conference call on May 18, 2026, to discuss its first quarter 2026 financial results.

Axe Compute Inc. announced a significant 36-month contract valued at approximately $260 million for a dedicated cluster of 2,304 NVIDIA B300 GPUs and AI storage.

Axe Compute reports Q1 2026 financial results, highlighting a strategic pivot to GPU compute services and a $260 million enterprise infrastructure contract.

Predictive Oncology Inc. reported a significant net loss of $82.17 million for the nine months ended September 30, 2025, driven by a $74.37 million derivative liability related to its new Aethir token (ATH) treasury strategy, while securing $50.8 million in cash and $173.3 million in ATH through private placements post-period.

Predictive Oncology Inc. reports continued significant losses, faces Nasdaq delisting, and is pursuing multiple capital raises and a reverse stock split to maintain operations and listing.

Predictive Oncology's Q1 2025 results reveal increased revenue driven by 3D model sales, alongside ongoing efforts to address financial uncertainties and the termination of a proposed merger with Renovaro.

Predictive Oncology's Q3 2024 results reflect a strategic shift with the discontinuation of its Birmingham operations, impacting revenue and profitability.

Predictive Oncology's Q2 2024 results show a decrease in revenue and a net loss, alongside the announcement of a strategic cost savings initiative.

Axe Compute Inc. reports a significant net loss for 2025 driven by digital asset volatility, while aggressively pursuing an AI compute and Aethir token treasury strategy.

Predictive Oncology Inc.'s 10-K filing reveals substantial doubt about its ability to continue as a going concern, despite efforts to secure additional funding and a proposed acquisition by Renovaro, Inc.

Predictive Oncology Inc. details the separation agreement with former CFO Robert Myers and files its annual report on Form 10-K, outlining financial results and business operations.

Axe Compute Inc. officer Joshua Blacher reports a transaction involving restricted stock units.

Director Theodore Zhu acquired 5,144 shares of Axe Compute Inc. common stock as compensation for board service.

Axe Compute Inc. director Charles Lee Nuzum Sr. acquired 14,082 shares of common stock as compensation for board services.

Axe Compute Inc. Director Veena Rao received 4,197 shares of common stock as compensation for board services on March 6, 2026.

Axe Compute Inc. director Shawn Matthews was issued 1,166 shares of common stock as compensation for his board service.

Director Gregory St. Clair Sr. acquired 9,419 shares of Axe Compute Inc. as compensation for board service, increasing his total holdings to 15,146 shares.

Predictive Oncology Inc. faces a "going concern" warning and seeks shareholder approval for significant equity issuance and an expanded incentive plan amidst substantial net losses and declining shareholder returns.

Predictive Oncology Inc. calls a Special Meeting to approve a 1:15 reverse stock split and a $10 million equity raise to maintain Nasdaq listing compliance.

Predictive Oncology Inc. has scheduled its annual stockholder meeting for December 30, 2024, to vote on the election of directors, ratification of auditors, approval of an equity incentive plan, and executive compensation.

Predictive Oncology Inc. has filed an S-1 registration statement to allow for the resale of up to 1.92 million shares by an institutional investor, potentially raising up to $10 million for the company, as it faces Nasdaq delisting for failing to meet listing standards and grapples with substantial doubt about its ability to continue as a going concern.

Kyle Okamoto and Okalina Ventures LLC disclose a 4.41% stake in Axe Compute Inc. following a crypto-based PIPE investment.